Research Interest: Microbiology, Immunology, Infectious Diseases and Their Prevention.

Research Interest: Viral replication, antiviral and anticancer drug development, mechanism of action of potential antiviral compounds, cellular metabolism and toxicity, pharmacokinetics, enzymology, kinetics.

Research Interest: Identification of Immunomodulatory, Effects of a Drug in Rhesus Monkey Model, Canonical Signaling Pathways.

Research Interest: HIV-1, Antivirals,Tissue; Ex Vivo, Pathogens.

Research Interest: Pediatric Epilepsy, Neuroinfections and Para Infectious Disorders, Developmental Neurology, Cerebral Palsy

Research Interest: Paediatric Dermatology, Contact and Occupational Dermatoses, Clinical Dermatology, Experimental Dermatology and Dermatosurgery.

Publications List:

1. Galabov, Angel S. (2017): On the action of N¹,N¹-anhydro-bis(β-hydroxyethyl)biguanide hydrochloride (abitylguanide, moroxidine, ABOB) versus RNA viruses. – Acta Microbiologica Bulgarica 32 (4), 221-223.

2. Petrov, N., A. S. Galabov (2017): Posttranscriptional gene silencing as a tool to control Coxsackievirus infections. – In: Microbiology for a Better Health and Industry (70^th Years Jubilee of the Stephan Angeloff  Institute of Microbiology, BAS) (H. Najdenski, Ed.),Sofia,  pp. 185-193.

3. Grozdanov, P., L. Simeonova, I. Nikolova, A. S. Galabov (2017): Detection of oral human papilloma viruses (HPV). - In: Microbiology for a Better Health and Industry (70^th Years Jubilee of the Stephan Angeloff  Institute of Microbiology, BAS) (H. Najdenski, Ed.),Sofia,  pp. 194-198.

4. Nikolaeva-Glomb, L., L. Mukova, N. Nikolova, V. Kussovski, L. Doumanova,

V. Mantareva, I. Angelov, D. Wöhrle, A. S. Galabov (2017): Photodynamic effect of some

phthalocyanines on enveloped and naked viruses. –Acta Virologica 61 doi:10, 4149/av _201_313.

5. Galabov, Angel S., Vesselina Vassileva, Vera Karabasheva (2017): Inhibitory effect of abitylguanide on adenovirus replication. –Drug Research  2017-02-1359/24.5.2017/MPS.

6. Angelova, A. L., M. Witzens-Harig, A. S. Galabov, J. Rommelaere (2017): The oncolytic virotherapy era in cancer management: prospects of applying H-1 parvovirus to treat blood and solid cancers. -  Frontiers in Oncology, https://doi.org/10.3389/ fonc.2017.00093.

7.  Arita, M., G. Dobrikov, G. Pürstinger, A. S. Galabov (2017): Allosteric regulation of phosphatidylinositol 4-kinase III beta by an anti-picornavirus compound MDL-860. – ACS Infect. Dis. DOI: 10.1021/acsinfecdis.7b0005.3

8. Galabov, Angel. S., Lucia Mukova, Yuriy P. Abashev, Lilia Wassilewa, Petko Tzvetkov, Vassil Minkov, Igor F. Barinskiy, Sergey Ouzounov, Dorotea Sidzhakova (2017): Cycluridine: A novel antiviral effective against flaviviruses. – Antivir. Chem. Chemother. 25: 58-67.

9.  Гълъбов, Ангел (2017): Популационна генетика на българите. – Форум, 2(2017): 40-46.

10. Dobrikov, G. M., I. Slavchev, I. Nikolova, A. Stoyanova, N. Nikolova, L. Mukova, R. Nikolova, B. Shivachev, Angel S. Galabov (2017): Synthesis and anti-enterovirus activity of new analogues of MDL-860-633. –  Bioorganic & Medicinal Chemistry Letters 27: 4540-4543.

11. Karachanak-Yankova, Sena, Desislava Nesheva, Draga Toncheva, Angel S. Galabov (2017): The uniparental genetic landscape of modern Slavic speaking populations. –

Advances in Anthropology 7(4): ID: 1590624.

12. Galabov, Angel S., Lubomira Nikolaeva-Glomb, Lucia Mukova, Emilia Ajvazova, Mimi Remichkova, Irina Georgieva, Monika Cseuz (2017): Large scale antiviral activity screening of a triple mixed herbal extract.- Intern. J. Herbal Medicine 5(5): 169-176.

13.  Нешева, Д., С. Карачанак-Янкова, А. Гълъбов, Д. Тончева (2017): Основни проблеми и решения при работа с древни кости и зъби. – Списание на БАН 6(2017): 56-59.

14. Vilhelmova-Ilieva, N., A. S. Galabov (2017): Tannins as natural helpers in reinforcement of human health. – Acta Microbiol. Bulg. 33 (3), 105-110.

15. Vilhelmova-Ilieva, N., S. Quideau, R. Jacquet, A. S. Galabov (2018): Castalagin: some aspects of the mode of anti-herpes viral activity. – Annals of Antivirals @ Antiretrovirals  doi.org/10.17352/aaa

16. Chayrov, R. L., E. K. Stylos, M. V. Chatziathanasiadou, K. N. Chuchkov, A. I. Tencheva, A. D. Kostagianni, T. S. Milkova, А. L. Angelova, A. S. Galabov, S. A. Shishkov, D. G. Todorov, A. G. Tzakos, I. G. Stankova (2018): Tailoring  acyclovir prodrugs with enhanced antiviral activity: rational design, synthesis, human plasma stability and in vitro evaluation. - Amino Acids, doi.org/10.1007/s00726-018-2590-y

17. Karaivanov, S., M. Manchev, A. S. Galabov (2018): Prophylactic effect of abitylguanide in nuclear polyedrosis of silkwarm.- Intern. J. Agriculture, Environment & Bioresearch 3(03): 163-175. IF=2.33.

18. Mileva, M., A. S. Galabov (2018): Vitamin E and Influenza virus infection.-

In: Vitamin E (ed. Morales-Gonzales), IntechOpen, London, pp. 67-82.

19. Galabov, A, S. (2018): Chemotherapy of Adenovirus Infections.-

In: Adenoviruses (ed. Y. A. Desheva), IntechOpen, London, pp. 123-28.

20. Galabov, A. S.,  L. NIkolaeva-Glomb, A. Stoyanova, I. Nikolova, N. Petrov, N.-Vilhelmova-Ilieva, R. Vassileva-Pencheva, Z, Salama (2018): Testing of silans for antiviral activity.- Acta Microbiol. Bulg. 34(3): 134-148.

21. Simeonova, L., L. Mukova, G. Gegova, A. S. Galabov, S. van der Werf (2018): Susceptibility to neurominidase inhiubitors and M2 blockers of seasonal influenza strains isolated in Bulgaria 2004-2007.- Acta Microbiol. Bulg. 34(4): 209-219.

22. Vilhelmova-Ilieva, N., R. Jacquet, D. Deffieux, L. Pouysegu, T. Sylla, S. Chassaing,

I. Nikolova, S. Quideau, A. S. Galabov (2019): Anti-herpes simplex virus type 1 activity of

specially selected group of tannins. – Drug Res. 69: 374-381.

23. Гълъбов, А. С. (2019): Вирусологията – моят път (второ допълнено издание).-

София, Прес Продъкт Лайн, издател (ISBN 978-619-7177-04-6), 230 стр.

24. Modi, A., D. Nesheva, S. Sarno, S. Vai, S. Karachanak-Yankova, D. Luiselli, E. Pilli, M. Lari, C. Vergata, Y. Yordanov, D. Dimitrova, P. Kalcev, O. Antonova, S. Hadjidekova, A. Galabov, D. Toncheva, D. Caramelli (2019): Ancient human mitochondrial genomes from Bronze Age Bulgaria: new insights into the genetic history of Thracians. – Scientific Reports 9:5412 [htttps://doi.org/10.1038/s41598-019-41945-0

25. Nikolova I. I. Slavchev, M. Ravutsov, M. Danglov, Y. Nikolova,  I. Zagranyarska, A. Stoyanova, N. Nikolova, L. Mukova, P. Grozdanov, R. Nikolova, B. Shivachev, V. E. Kuz’min, L. N. Ognichenko, A. S. Galabov, G. M. Dobrikov (2019): Anti-enteroviral activity of new MDL-860 analogues: synthesis, in vitro/in vivo studies and QSAR analysis. –

Bioorg. Chem. 85: 487-497.

26. Mastikova,  M., A. S. Galabov, A. A. Karparov, P. Dosseva-Rnevska (2019):

Antiviral activity od dipyridamole in experimental viral infections in mice.- Acta Microbiol. Bulg. 35: 46-52.

27. Petrov, N., M. Stoyanova, A. Galabov (2019): Inhibition of coxsackievirus b3 cardiotropic strain Woodruff replication by silencing essential viral genes.- Biotechn. Biotechnol. Equip. 33: 1582-1589.

28. Stankova, I., K. Chuchkov, R. Chayrov, L. Mukova, A. Galabov, D. Marinkova,  D. L. Danalev (2019): Adamantаne derivatives containing thiazole moiety – synthesis, antiviral and antibacterial activity.- J. Peptide Res. & Therapeutics, DOI: 10.1007/s10989-019-09983-4.

29. Vilhelmova-Ilieva, N., A. S. Galabov, M. Mileva 92019): Tannins as Antiviral Agents.-

In: Tannins, IntechOpen, London.

30. Grozdanov, P., M.-L. Joffret, A. Stoyanova, , P. Polston, I. Nikolova, F. Delpeyroux,

A.  S. Galabov (2020): Genome analysis of coxsackievirus B1 isolates during the consecutive alternating administration course of  triple antiviral combination in newborn mice. –

Antivir. Chem. Chemother. 28: 1-6.

31. Mileva, M., A. Dimitrova, D. Krastev, A. Alexandrova, E. Tsvetanova, A. Georgieva,   A. Galabov (2020):  Oseltamivir and S-adenosyl-L-methionine combination as effective therapeutic strategy for suppression of oxidative damage in lung  caused by influenza virus infection in mice. –  Drug Res. 70: 273-279.

32. Galabov, A. S., S. A. Galabov (2020): Antivirals effective toward SARS-CoV-2. –

Acta Microb. Bulg. 36: 3-8.

33. Vilhelmova, N., L. Simeonova, N. Nikolov, E. Pavlova, Z. Gospodinova, G. Antov, A. Galabov, I. Nikolova (2020): Antiviral, cytotoxic and antioxidant effects of Tanacetum vulgare L. crude extract in vitro. – Folia medica 62: 172-179.

34. Гълъбов, А. С. (2020): COVID-19. – Наука 30 (1): 12-16.

35. Mukova, L., A.  S. Galabov (2020): Study of urotropin for virucidal action toward  HSV-1 and HSV-2. – Acta Microb. Bulg. 36: 68-69.

.

36. Vilhelmova-Ilieva, N., I. Sirakov, R. Jacquet, D. Deffieux, S. Quideau, A. S. Galabov(2020): Antiviral activities of ellagitannins against bovine herpesvirus 1, suid alphaherpesvirus 1 and caprine herpesvirus 1. – J. Vet. Med. & Animal Health 12(4): 139-143.

37. Stoyanova, A., A. S. Galabov (2020): Effect of consecutive alternating administration of a triple combination of anti-enteroviral compounds in mice infected with Coxsackievirus B3.- Pathogens and Disease 78, ftaa065.

38. Mileva, M., A. Dimitrova, D. Krastev, A, Alexandrova, E. Tsvetanova,  A. Galabov (2020): Oseltamivir and 5-adenosyl-L-methionine combination as effective therapeutic strategy for suppression of oxidative damage in lung caused by influenza virus infection in mice. – Drug Res. 70: 273-279.

39. Galabov, A. S. (2021): Dipyridamole as an interferon inducer.  – Acta Microbiologica Bulgarica 37: 3-9.

40. Vilhelmova-Ilieva, N., K. Idakieva, L. Doumanova, A. S. Galabov (2021): Antiviral Activity of Rapana thomasiana hemocyanin against bovine rotavirus.- Acta Microbiologica Bulgarica 37: 46-50.

41. Stoyanova, A., A. S. Galabov (2021a): Consecutive alternating adminiatration as effective anti-coxsackievitus B3 in vivo .- Archives of Virology 10.1007/s00705-021-05057-3.

42. Galabov, A. S. (2021): Dipyridamole as an Antiviral Agent.  –  In:  Recent Progress in Microbiology and Biotechnology vol. 5 ( Makky, E. A., ed.) Chapter 6. Book Publisher International, Hoogly . India, United Kingdom, pp.67-77. DOI: 10.9734/bpi/rpmb/v5/1942F.

43. Galabov, A. S., A. Stoyanova (2021): On the Effective Antiviral Treatment of Enterovirus Infections. –  In:  Recent Progress in Microbiology and Biotechnology vol. 5 ( Makky, E. A., ed.)  Chapter 10. Book Publisher International, Hoogly.  India, United Kingdom, pp. 101-116, DOI: 10.9734/bpi/rpmb/v5/1929F.

44. Dimitrova, A., M. Mileva, D. Krastev, I. KIndekov, A. S. Galabov (2021): Multiorgan pathological changes caused by experimental influenza virus infection in mice. –  C. r. Acad. Bulg. Sci. 74: 1479-1487.

45. Stoyanova, A., A. S. Galabov (2022): Effect of double combinations of enterovirus replication inhibitors towards coxsackie B viruses. – Acta virologica 65: 411-419.

46. Тончева, Д., A. Гълъбов, Д. Нешева (2021): Характеристика на антропогенетичния произход на българите. - In: България и Македония. История и политика. Първа част (Ред. Бианка Пашкова), Издателство: Македонски научен институт/Тангра, ИК, София, стр. 127-148.

47. Galabov, A. S., A. Stoyanova (2022): Consecutive alternating administration of triple combination of virus inhibitors as a new therapy of enterovirus infection. – In: Petrova, P., Angelova, M., Krumova, E., Kabaivanova, L. (eds.).Modern Microbiology: a Challenge for Improving the Quality of Life. 75^th Years Anniversary of the Stephan Angeloff  Institute of Microbiology. Publ. House “Farago”, Sofia. pp. 179-191.

48.. Vihelmova-Ilieva, N., I. Nikolova, M. Mileva, Z. Petrova, P. Grozdanov, N. Nikolova, M. Tre[pechova, A.  S. Galabov (2022): Natural products inhibitors of human and animal herpes viruses. – In: Petrova, P., Angelova, M., Krumova, E., Kabaivanova, L. (eds.).Modern Microbiology: a Challenge for Improving the Quality of Life. 75^th Years Anniversary of the Stephan Angeloff  Institute of Microbiology. Publ. House “Farago”, Sofia. pp. 201-211.

49. Mileva, M., D. Krastev, E. Tsvetanova, A. Georgieva, A. Alexandrova, A. Dimitrova, L. Mukova. A. S. Galabov (2022): Oseltamivir and S-adenosyl-L-methionine combination as an effective therapeutic strategy for suppression of oxidative damages caused by influenza virus infect ion in mice.- In: Petrova, P., Angelova, M., Krumova, E., Kabaivanova, L. (eds.).Modern Microbiology: a Challenge for Improving the Quality of Life. 75^th Years Anniversary of the Stephan Angeloff  Institute of Microbiology. Publ. House “Farago”, Sofia. pp. 220-229.

50. Hristova, N., А. Stoyanova, S. A. Galabov, А. S. Galabov (2022): Preparation of HSV-1 and HSV-2 strains with increased virulence. – Acta Microbiologica Bulgarica 18: 40-47.

51.. Petrov, N., M. Stoyanova, A. Stoyanova, I. Nikolova, P. Grozdanov, A. Galabov (2022):

Gene silencing of VP1 gene of coxsackievirus B3 neurotropic strain Nancy by dsRNAs and siRNAs. – Biotechnol. Biotechnol. Eq. 36: 353-361.

52. Гълъбов, А. С. (2022): Есберитокс и неговото приложение в клиничната практика.- Medinfo 2022/10: 28-32.

53. Nikolova, I., I. Slavchev, I. Zagranyarska, N. Nikolova, N. Vilhelmova, A. Stoyanova, P. Grozdanov, L. Mukova, A. S. Galabov, I. Lessigiarska, I. Tsakovska, G. Dobrikov (2022):

Synthesis and QSAR analysis of diarylethers and their analogues as potential antiviral agents.- Chem. Med. Chem., in press.

54. Hristova, N., A. S. Galabov (2022): Genus Simplexvirus: clsification, morphology and genom organization. –  Acta Microbiologica Bulgarica 38 (4): 280-288.

55. Гълъбов, А. С., Х. Найденски (2022): Луи Пастьор: 200 години от рождението.-

Списание на Българската Академия на науките. 2022/6: 57-61.

56. Mileva, M., A. Dimitrova-Koleva, E. Tsvetanova, D. Krastev, A. Georgieva, A. Alexandrova, A. S. Galabov (2022): Mitigation of  the oxidative damage in liver caused by influenza virus infection in mice by an effective  combination of oseltamivir and S-adenosyl-L-methionine (SAM). -J. Pharmacy and Nutrition Sciences 12:

57. Hristova, N., A. S. Galabov (2023): Genus Simplexvirus: life cycle.- Acta Microbiologica Bulgarica. 39:16-22

58. Hristova, N., A. S. Galabov (2023): Pathogenesis, diseases, immune response and chemotherapy of genus Simplexvirus. – Acta Microbiologica Bulgarica 39: 102-110.

59. Stoyanova, A., A. Popatanasov, V. Rashev, L. Tancheva, S. Quideau, A. S. Galabov (2023): Effect of castalagin against HSV-1 infection in newborn mice. – Natural Product Research 37: 4156-4161. GNPL#2173191

60.. Galabov, A. S., A. Stoyanova, S. A. Galabov (2023): Терапия на ентеровирусните инфекции.- Природа 2023/2: 14-19

61. Гълъбов, А. С., Хр. Найденски (2023): История на Института по микробиология „Стефан Ангелов“ при  БАН и предизвикателствата към него през XXI век. - Списание на  БАН 136, 5/2023: 37-47

62. Stoyanova, A., S. A. Galabov, N. Hristova, V. Makarov, A. S. Galabov (2023):  Antiviral effect of triple combination of VP1 ligsnds against Coxsackievirus B3 in newborn mice. - Acta Microbiol. Bulg. 39: 386-391.

63. Ianevski, A., I.T. Frøysa, Hilde 39525; C. Calitz, T. Smura, H.-J. Schjelderup Nilsen, E. Høyer, J.. E. Afset,  A.Sridhar, K. C. Wolthers, E. Zusinaite, T. Tension, R. Kurg, V. Oksenych, A. S. Galabov, A. Stoyanova, M. Bjørås, D. Kainov (2024): The combination of pleconaril, rupintrivir, and remdesivir efficiently inhibits enterovirus infections in vitro, delaying the development of drug-resistant virus variants. - Antiviral Research 224. 105842.

64. Витанов, П., M. Христов, И. Димов, A. С. Гълъбов (2024): Българският принос в третата индустриална революция. - Списание на БАН  155/2: 15-20.

65. Stoyanova, A., S. Galabov, A. S. Galabov (2024): Antiviral activity in vitro of double combinations of enteroviral inhibitors. - Acta Virologica. Frontierspartnerships.org.

Research Interest: Alzheimer's Disease, Nanoparticles, Hydrogels, Biomaterials

Research Interest: HIV-1, Retrovirology, Retroviruses, Splicing, Genetics and Molecular Biology, Chromatin Biology, NGS, Bioinformatics, Geneom Analysis.

Research Interest: Plant Viruses; Virus-Host Interaction; Viral Infection; Anti-Viral Research

Research Interest: Vaccine, Vaccinology, HIV, gp41, Animal Trials